Verve Therapeutics Inc (NASDAQ:VERV) price on Wednesday, April 30, rose 3.85% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.67. A look at the stock’s price movement, the close in the last trading session was $5.46, moving
Verve Therapeutics Inc (NASDAQ:VERV) price closed lower on Friday, April 25, and dropping -0.35% below its previous close. A look at the daily price movement shows that the last close reads $5.78, with intraday deals fluctuated between $5.63 and $5.9189. The company’s 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) traded at $4.78 at close of the session on Monday, April 21 and made an upward move of 4.14% on its previous day’s price. Looking at the stock we see that its previous close was $4.59 and the beta (5Y monthly)
Verve Therapeutics Inc (NASDAQ:VERV) price closed lower on Friday, April 04, and dropping -5.85% below its previous close. A look at the daily price movement shows that the last close reads $3.85, with intraday deals fluctuated between $3.465 and $3.74. The company’s 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) concluded the trading at $3.91 on Wednesday, April 03 with a fall of -5.44% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $4.14 and 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) shares, rose in value on Friday, March 28, with the stock price down by -1.14% to the previous day’s close as strong demand from buyers drove the stock to $5.22. Actively observing the price movement in the last trading, the stock
The trading price of Verve Therapeutics Inc (NASDAQ:VERV) closed higher on Friday, March 21, and closing at $5.55, 0.18% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $5.26 and $5.61. In examining the
Verve Therapeutics Inc (NASDAQ:VERV) price closed lower on Tuesday, March 18, and dropping -8.70% below its previous close. A look at the daily price movement shows that the last close reads $6.32, with intraday deals fluctuated between $5.77 and $6.21. The company’s 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) concluded the trading at $6.15 on Thursday, March 13 with a fall of -4.21% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $6.42 and 5Y monthly beta
Verve Therapeutics Inc (NASDAQ:VERV) traded at $6.71 at close of the session on Friday, March 07 and made an upward move of 1.51% on its previous day’s price. Verve Therapeutics Inc has a market cap of $595.82 million and is expected to release its quarterly
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
